We rely on your support for our independence, diversity and quality. Fair Observer is a 501(c)(3) independent nonprofit. We are not owned by billionaires or controlled by advertisers. We publish ...
The npm package has a module field pointing to an ES module variant of the library, mainly to provide support for ES module aware bundlers, whereas its browser field points to an UMD module for full ...
Abstract: The decentralization mechanism provides manufacturers and distributors with greater customization and flexibility they need through Internet of Things (IoT)-based industrial collaboration ...
ATTR-cm is often underdiagnosed or misdiagnosed, leading to limited data surrounding its true prevalence. The lack of data concerning ATTR-cm prevalence is due to; common symptoms with other diseases ...
With several disease-modifying therapies available for transthyretin amyloid cardiomyopathy (ATTR-CM) -- and more waiting in the wings -- choosing one has become a new challenge, with softer endpoints ...
MINNEAPOLIS, MN—Treatment with acoramidis (Attruby; BridgeBio Pharma) compared with placebo appears to reduce cumulative cardiovascular events by almost half among patients who have transthyretin ...
According to a well-known anecdote, when former US Secretary of State Henry Kissinger met with Chinese Premier Zhou Enlai in 1971 to prepare for the Richard Nixon–Mao Zedong summit, Kissinger asked ...
The word “amyloidosis” has been a part of my life since 2009. Initially, I encountered it as a caregiver to my dad, who ultimately passed away in 2010. The term resurfaced in 2020 when I was diagnosed ...
BridgeBio (BBIO) Pharma presented initial outcomes from the ATTRibute-CM open-label extension study of acoramidis in ATTR-CM at the American Heart Association Scientific Sessions. ATTRibute-CM was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results